| HOME >> BIOLOGY >> TECHNOLOGY |
87,290178,99327,334Total shareholders’ equity 808,8861,070,781163,520Noncontrolling interests10,72222,6113,453Total equity819,6081,093,392166,973Total liabilities and equity1,047,0341,563,598238,780CHINA CORD BLOOD CORPORATIONUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONSFor the Three Months and Year Ended March 31, 2010 and 2011Three months ended March 31,Year ended March 31,2010201120102011RMBRMBUS$RMBRMBUS$(in thousands except per share)Revenues
70,80694,67114,457261,536339,53251,850Direct costs
(15,115)(20,001)(3,054)(65,730)(77,376)(11,816)Gross profit55,69174,67011,403195,806262,15640,034Operating expensesResearch and development
(5,816)(1,717)(262)(5,816)(6,960)(1,063)Sales and marketing
(12,553)(13,273)(2,027)(39,480)(47,583)(7,266)General and administrative
(12,421)(23,251)(3,551)(53,317)(83,794)(12,796)Total operating expenses
(30,790)(38,241)(5,840)(98,613)(138,337)(21,125)Operating income24,90136,4295,56397,193123,81918,909Other income, netInterest income
1,3652,6944116,4119,0651,384Interest expense
(619)(657)(100)(2,431)(2,606)(398)Exchange (loss)/gain
(1,020)(61)(9)(417)48674Write-off of deferred reverse capitalization costs
---(21,566)--Others
148269414731,378210Total other (expense)/income, net
(126)2,245343(17,530)8,3231,270Income before income tax
24,77538,6745,90679,663132,14220,179Income tax expense
(7,199)(10,867)(1,660)(24,770)(33,929)(5,181)Net income17,57627,8074,24654,89398,21314,998Income attributable to noncontrolling interests
(1,447)(1,548)(236)(5,369)(6,510)(994)Income attributable to redeemable noncontrolling interests
---(347)--Net income attributable toshareholders16,12926,2594,01049,17791,70314,004Net income per share:Attributable to ordinary shares-Basic
0.240.350.050.821.310.20-Diluted
0.230.350.050.781.310.20
'/>"/>
| SOURCE China Cord Blood Corporation Copyright©2010 PR Newswire. All rights reserved |